Singapore study suggests much shortened treatment period for TB patients

Tuberculosis (TB) patients can look forward to a much-shortened treatment period, compared to the current six-month trea...

April 8, 2023 | Saturday | News
Australia injects $12 M more into world-first childhood diabetes study

JDRF Australia and funding partner The Leona M. and Harry B. Helmsley Charitable Trust have announced a combined additio...

April 8, 2023 | Saturday | News
Thailand makes progress in CAR T-Cell Therapy Innovation

Chulalongkorn University, Thailand, and Nagoya University, Japan, in their collaboration to develop an immunotherapy met...

April 6, 2023 | Thursday | News
Korea-Singapore research offers simultaneous diagnosis and treatment of cancer

A research team from South Korea-based Pohang University of Science and Technology (POSTECH) collaborated with researche...

April 3, 2023 | Monday | News
Sepsis study in Australia to power new antibiotic discoveries

Australia's University of Queensland (UQ) researchers have led a national study on the four main bacteria that cause sep...

April 4, 2023 | Tuesday | News
Funding boost for world-first cell transplantation research for nervous system repair in Australia

Australia-based Griffith University’s world-first study into cell transplantation to repair injuries to the nervou...

March 31, 2023 | Friday | News
Novel drug from New Zealand offers hope for heart failure patients

A novel drug is showing promise for alleviating heart failure, a common condition associated with sleep apnoea and a red...

March 30, 2023 | Thursday | News
Australian study of ENZAMET shows promise as prostate cancer treatment

A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates. The result...

March 29, 2023 | Wednesday | News
New funding by NZ to boost RNA research into vaccines & healthcare

Victoria University of Wellington and University of Auckland, in New Zealand (NZ) have been named as co-hosts of a ...

March 27, 2023 | Monday | News
Duke-NUS in Singapore partners with Swedish biotech startup Alder Therapeutics

In a boost to regenerative therapies for damaged hearts and eyes, Duke-NUS in Singapore has licensed two laminin-related...

March 24, 2023 | Friday | News
Australia injects $3M funding for world-first drug trial for poorly controlled epilepsy

Epilepsy affects over 150,000 Australians, and 50 million globally, with one-third struggling to control their condition...

March 22, 2023 | Wednesday | News
Singapore finds new way to clear brain waste linked to Alzheimer's disease

A newly discovered “energy switch” in the immune cells of the brain may lead to the development of drugs for...

March 17, 2023 | Friday | News
Australia uses smart nanotechnology for more accurate delivery of insulin

More efficient and longer lasting glucose-responsive insulin that eliminates the need for people with type 1 diabetes to...

March 14, 2023 | Tuesday | News
World's first study to prove myopia prevention in children by low-concentration atropine drops

The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) conducted a randomised, placebo-con...

March 14, 2023 | Tuesday | News
Breakthrough neurological drug comes from New Zealand to treat Rett Syndrome

A molecule discovered by Distinguished Professor Dame Margaret Brimble of the University of Auckland, New Zealand is the...

March 13, 2023 | Monday | News
Monash University in Australia leads $15M mitochondrial donation clinical trial

Around 50 Australian children are born every year with devastating mitochondrial disease, with an expected lifespan of o...

March 13, 2023 | Monday | News
Singapore develops novel therapy for treating vancomycin-resistant bacterial infections

Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for...

March 8, 2023 | Wednesday | News
"We will enable researchers in Singapore to conduct homegrown large-scale population health studies"

  Please share more details about the technology that has been transferred by Olink to NUS? What is so unique...

March 7, 2023 | Tuesday | Opinion
Singapore accelerates precision medicine through next-generation proteomics

The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has launched the NUS Medi...

March 7, 2023 | Tuesday | News
Japan discovers potential treatment of autoimmune diseases

Scientists in Japan have revealed a chemical compound that could be used for the treatment of various autoimmune disease...

March 7, 2023 | Tuesday | News
European Union approves first gene therapy for hemophilia B

Australian biotechnology leader CSL has announced that the European Commission has granted conditional marketing authori...

February 23, 2023 | Thursday | News
Korean firms to develop novel microbiome treatment for Parkinson's disease

South Korean startup LISCure Biosciences Inc. has announced a multi-year strategic R&D collaboration with Celltrion ...

February 21, 2023 | Tuesday | News
New Zealand approves globally regarded soft-tissue sarcoma therapy

Singapore-headquartered biopharmaceutical company Specialised Therapeutics (ST) has announced that its portfolio therapy...

February 17, 2023 | Friday | News
Australia discovers receptor that blocks COVID-19 infection

Australia's University of Sydney scientists have discovered a protein in the lung that blocks SARS-CoV-2 infection and f...

February 14, 2023 | Tuesday | News
Japan develops method to design new peptide therapeutics for combating antibiotic resistance

Applications of new molecules as drugs are expected to be effective in treating diseases that are difficult to cure with...

February 13, 2023 | Monday | News